From RUO to Trial-Ready in Six Months Accelerating an FGFR NGS Patient-Selection Assay for a Global Phase 3 Solid Tumor Cancer Trial
CellCarta Case Study
July 2026
Summary Report from the Royal College of Pathologists Forum: Rapid Genomic Testing for Cancer Patients
Publication Source: Royal College of Pathologists
TBC
oncoReveal Methylation Panels, Workflow and performance overview of targeted methylation NGS panels
Publication Source: Pillar Biosciences White Paper
TBC
Targeted NGS as a Frontline Strategy to Accelerate the Precision Treatment of Solid and Heme Tumors
Publication Source: GenomeWeb
TBC
Diagnostics, access, therapies on minds ahead of ASCO
Publication Source: CAP TODAY
TBC
Validation and Performance of Quantitative BRCA1 and RAD51C Promoter Hypermethylation Testing in Breast and Ovarian Cancers
Publication Source: The Journal of Molecular Diagnostics
TBC
Need for speed in solid tumor molecular testing
Publication Source: CAP TODAY
TBC
Minimizing Sample Failure Rates for Challenging Clinical Tumor Samples
Publication Source: The Journal of Molecular Diagnostics
TBC
Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for BRCA Methylation Testing?
Publication Source: American Society of Clinical Oncology
TBC
Quality metrics for enhanced performance of an NGS panel using single-vial amplification technology
Publication Source: Journal of Clinical Pathology
TBC